Real‐world dosing characteristics and utilization of parenteral treprostinil in the outpatient setting
Abstract Real‐world dosing and titration of parenteral (subcutaneous, SC; intravenous, IV) prostacyclin, a mainstay of pulmonary arterial hypertension (PAH) treatment, is not always consistent with prescribing information or randomized trials and has yet to be adequately characterized. The current s...
保存先:
| 主要な著者: | , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Wiley
2022-01-01
|
| シリーズ: | Pulmonary Circulation |
| 主題: | |
| オンライン・アクセス: | https://doi.org/10.1002/pul2.12016 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|
